The Drug Enforcement Administration (DEA) is backing down from a much-criticized proposal that would have required patients to visit a doctor in person before receiving prescriptions for certain controlled substances via telemedicine.The rule change was set to go into effect after the COVID public health emergency expires later this week, but following an overwhelming public outcry, the DEA has extended its public comment period for another six months and will allow anyone who begins their telehealth treatment by that time to continue their care until November 2024.
[
add
]
[
|
|
...
]